Pharmaceutical alternatives

How is Pharmaceutical alternatives defined in a legal contract?

• Pharmaceutical alternatives means different drug products that have the same core ingredient but vary in attributes like form (salt, ester, etc.), pharmaceutical form or strength. Seen in 4 SEC filings.
• Pharmaceutical alternatives means drug products that have the same therapeutic core but not necessarily in the same amount, form or variant (such as salt or ester). Each of these products meets either the same or specific standards of identity, strength, quality, and purity, including potency and, where applicable, content uniformity and dissolution rates. Seen in 1 SEC filing.

Note: The Genie AI Legal Assistant pulled this data out of the SEC EDGAR Database of 500,000 records from the past 22 years of filings. We regularly update this page as new filings and definitions come in.

Search EDGAR for 'Definitions of pharmaceutical alternatives' yourself to verify these results. We are always keen to point people to source documents.

‍

Which definition should you use?

🤔 Our AI Legal Assistant has combined and improved the above descriptions to create market-standard 'Genie definitions' below, with guidance on which documents and which industry to use for each.

‍

Genie Definition 1

• Pharmaceutical alternatives means medicinal products with the same core ingredient but differ in physical form, variant, strength, or dosage.

Relevant Contract Types

• Pharmaceutical Licensing Agreement
• Research and Development Agreement
• Supply and Distribution Agreement
• Joint Venture Agreement
• Manufacturing and Supply Agreement

Relevant Circumstances

• Negotiations for supply and distribution partnerships.
• Development and licensing of new pharmaceutical formulations.
• Collaborative research and development projects.
• Setting quality standards in manufacturing agreements.

Relevant Sectors

• Healthcare
• Pharmaceuticals
• Life Sciences
• Biotechnology

‍